Articles related to HEALTHCARE FUNDING

The federal government has sharply reduced staffing and grant funding at AHRQ, the agency responsible for much of the nation’s healthcare quality and patient safety research. Supporters argue the cuts could affect future evidence generation, though the administration maintains it is restructuring agency priorities.

US prescription drug expenditures reached $915.2 billion in 2025, with utilization growth rather than price increases accounting for the majority of the 12.7% rise, and clinic-sector spending projected to outpace hospital spending by a factor of three in 2026.

Falling Medicaid enrollment under the One Big Beautiful Bill Act is eroding the disproportionate share hospital percentages that determine 340B Drug Pricing Program eligibility at safety-net hospitals, according to a presentation at HOPA 2026.

Lifesaving research projects on cancer, vaccine hesitancy, and health equity are being denied funding for political reasons.

Cancer research infrastructure faces its most severe funding crisis in over two decades, with institutions forced to choose between maintaining current studies and preserving workforce capacity for future breakthroughs.